The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEqtec Regulatory News (EQT)

Share Price Information for Eqtec (EQT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.85
Bid: 1.80
Ask: 1.90
Change: 0.00 (0.00%)
Spread: 0.10 (5.556%)
Open: 1.85
High: 1.85
Low: 1.85
Prev. Close: 1.85
EQT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Apr 2022 16:30

RNS Number : 4739I
EQTEC PLC
14 April 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

IE00BH3XCL94

Issuer Name

EQTEC plc

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Amati Global Investors Limited

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

TB Amati Investment Funds

Nottingham

United Kingdom

5. Date on which the threshold was crossed or reached

13-Apr-2022

6. Date on which Issuer notified

14-Apr-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.980000

0.000000

4.980000

429060473

Position of previous notification (if applicable)

6.79

6.79

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

IE00BH3XCL94

429060473

4.980000

Sub Total 8.A

429060473

4.980000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

14-Apr-2022

13. Place Of Completion

Edinburgh, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLIIMATMTTBBMT
Date   Source Headline
19th Apr 20247:45 amRNSUpdate on Verde Corporation Subscription
5th Apr 202410:13 amRNSHolding(s) in Company
3rd Apr 20243:09 pmRNSSettlement Agreement with Logik Developments
2nd Apr 20247:00 amRNSUpdate on Verde Corporation Subscription
11th Mar 20247:00 amRNSUpdate on Verde Corporation Subscription
29th Feb 20247:17 amRNSUpdate on Initial Subscription
22nd Feb 20248:09 amRNSUpdate on Initial Subscription
13th Feb 20245:00 pmRNSHolding(s) in Company
13th Feb 20248:17 amRNSHolding(s) in Company
13th Feb 20247:00 amRNSNew Investor Subscription and Debt Conversion
16th Jan 20241:16 pmRNSJoint Venture with CompactGTL
16th Jan 20247:00 amRNSDrawdown of Bank Refinance Approved for Italy MDC
21st Dec 20237:00 amRNSItaly MDC - Refinance Update & Conversion Notices
18th Dec 20231:30 pmRNSResults of EGM
7th Dec 20237:00 amRNSEquipment Supply Agreement for Plant in USA
29th Nov 20237:00 amRNSTechnical Services Agreement for Plant in USA
28th Nov 20237:00 amRNSAchievement of ISO certifications
27th Nov 20237:00 amRNSCollaboration Framework Agreement
24th Nov 20237:00 amRNSNotice of EGM
20th Nov 20237:00 amRNSRefinancing of Debt Facilities and Company Update
6th Nov 20238:39 amRNSItalia MDC update and share ownership
16th Oct 20237:00 amRNSDirector/PDMR Shareholding
13th Oct 20234:28 pmRNSDirector/PDMR Shareholding
6th Oct 202310:55 amRNSHolding(s) in Company
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 20232:25 pmRNSDirector Dealing
28th Sep 20237:00 amRNSInterim results
26th Sep 20237:00 amRNSProject update
20th Sep 20234:15 pmRNSLegal claim against Logik Developments
20th Sep 202312:25 pmRNSDiscontinuation of Billingham Project
4th Sep 20237:00 amRNSBank Refinance of Italy Market Development Centre
17th Aug 20237:00 amRNSContract signed with Idex for FEED at France MDC
31st Jul 20237:00 amRNSSuccessful Steam-Oxygen Gasification Tests
25th Jul 20237:00 amRNSCollaboration Framework Agreement with Domi Ost
12th Jul 20237:00 amRNSSale of France Market Development Centre to Idex
23rd Jun 20239:40 amRNSGrant of Long-term Incentive Plan Options
22nd Jun 202312:55 pmRNSCompletion of Italy MDC handover
21st Jun 20234:15 pmRNSResults of 2023 AGM
25th May 20237:00 amRNSNotice of 2023 AGM
5th May 20237:00 amRNSFinal Results
21st Apr 20234:30 pmRNSResult of Broker Option
18th Apr 20237:00 amRNSPublication of 2022 annual report
17th Apr 20232:15 pmRNSCollaboration Framework Agreement
4th Apr 20237:00 amRNSUpdate re Director remuneration and Broker Option
27th Mar 20237:00 amRNSFrance project award with Idex Group
23rd Mar 20237:00 amRNSFrance government award for potential RNG project
21st Mar 202311:05 amRNSSecond Price Monitoring Extn
21st Mar 202311:00 amRNSPrice Monitoring Extension
21st Mar 20238:14 amRNSProposed Equity Issue to raise approximately £3.5m
14th Mar 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.